Although there is limited information on the pathophysiological significance of ANGPTL6 up-/downregulation in humans under different metabolic statuses, emerging evidence has revealed that serum ANGPTL6 levels were increased in individuals suffering from type 2 diabetes, metabolic syndrome, and preeclampsia [135,136,137,138]. This evidence concerns the gene ANGPTL6 and metabolic syndrome.